This restoration of Treg function opens up the possibility of reprogramming the metabolism of deficient Treg (such as in IPEX disease where mutations to FOXP3 are common) by targeting particular metabolic pathways (summarized in Figure 4). This evidence concerns the gene FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.